Skip to content

CAP22 Abstract Program

Important Dates to Remember

January 10, 2022

Abstract submission begins at 9:00 AM CT

March 11, 2022

Abstract submission closes at 5:00 PM CT

May 27, 2022

Corresponding authors notified of submission status

August 17, 2022

Top 5 Junior Member Abstract Program winners notified

Program Description

The CAP22 Abstract Program is a competitive program sponsored by the College of American Pathologists. The program is designed to promote a broad range of research in pathology. It offers pathologists and research scientists the opportunity to present original research to their peers in a poster presentation format. Editors from the Archives of Pathology & Laboratory Medicine will evaluate submissions to this program.

In addition, the CAP22 Abstract Program provides a unique opportunity for residents to enhance research skills, develop writing proficiency, gain practical experience at presenting their findings, and contribute to the literature and advancement of pathology. Accepted abstracts and case studies will be published as a Web-only supplement to the September 2022 issue of the Archives. While the CAP22 meeting will have a hybrid format, accepted authors will present their research as a physical poster at the meeting; an ePoster component will not be offered this year. CAP junior members who have their abstracts accepted are eligible for cash awards as part of the Top 5 Junior Member Abstract Program.

Submissions to the CAP22 Abstract Program are no longer being accepted.

CAP22 Abstract Program Evaluation Criteria

Abstracts will be evaluated on the following criteria:

  • Significance of the hypothesis
  • Valid conclusion(s)
  • Argument clarity
  • Presentation quality

Case studies must include novel findings, such as the following:

  • A new disease or condition (i.e. not previously reported).
  • A distinctive or unusual presentation of a known disease, with one or more well-documented new findings of special clinical relevance (i.e., potentially applicable to diagnosis, therapy, prognosis, etc.) or that serves to provide new insight into the possible pathogenesis of a disease (hypothesis-generating). The new information might be derived from distinctive morphology and/or ancillary testing.
  • A known disease with a demonstrated new finding using state-of-the-art techniques (immunohistochemical, molecular, 3-dimensional reconstruction, cytogenetics, etc.) relevant to a clearly stated hypothesis.

A known disease presenting with a previously undescribed clinically or etiologically relevant association (i.e., a myelodysplastic syndrome associated with a plasma cell dyscrasia, etc.) to heighten awareness of a possible link between entities. Such a link might have been described before in one or more individual case reports, and the addition of a case might help solidify a real association.

Submission Categories

Abstracts and case studies may be submitted to the following categories:

Anatomic Pathology

Autopsy and forensic pathology

Bone and soft tissue pathology

Breast pathology

Cardiovascular pathology



Endocrine pathology

Head, neck, and oral pathology

Ophthalmic pathology

Gastrointestinal and liver pathology

Gynecologic and placental pathology

Kidney and genitourinary pathology


Pulmonary and mediastinal pathology

Clinical Pathology

Clinical chemistry

Clinical immunology



Molecular pathology

Transfusion medicine and coagulation


Practice Management

Administrative and regulatory affairs


Pathology education

Practice management

Quality assurance

Author Requirements

Corresponding authors must be available to respond to questions about the content of their submissions from the Archives editorial office, especially during the period of April 12 to May 23, 2022. E-mail addresses for corresponding authors must be active and accessible through August 2022.

Corresponding authors will be notified of their submission status on May 27, 2022. Authors of accepted submissions will receive specific information regarding poster presentation requirements in their acceptance notification email on May 27.

CAP Top 5 Junior Member Abstract Program

Authors of the top 5 accepted abstracts received from CAP junior members will be named as the Top 5 Junior Member Abstract Program award winners and given cash prizes:

  • First place cash award = $1,500
  • Second place cash award = $1,000
  • Third place cash award = $750
  • Fourth and fifth place cash awards are $500 each.

To be eligible for the CAP22 Top 5 Junior Member Abstract Program awards, a CAP junior member must:

  1. Have performed a substantial portion of the research and work involved in the preparation of the abstract;
  2. Be listed as either the first or second author;
  3. Serve as the corresponding author.

Top 5 Junior Member Abstract Program award winners will be notified by August 17, 2022.


If you have questions about the abstract program, please e-mail prior to completing your submission. Your questions will be routed to the abstract program coordinator.

Remember, submissions cannot be changed or resubmitted after the submission deadline. Carefully review and spell-check your abstracts and case studies prior to submitting them to the CAP22 Abstract Program.